Emicizumab does not interfere with the activated clotting time
Sign Up to like & getrecommendations! Published in 2022 at "Haemophilia"
DOI: 10.1111/hae.14497
Abstract: The activated clotting time (ACT) is a useful marker of unfractionated heparin (UFH) activity during cardiopulmonary bypass (CPB) or cardiac catheterization. Emicizumab, recently approved for bleeding prevention in haemophilia A patients, acts like FVIII but… read more here.
Keywords: emicizumab interfere; interfere activated; activated clotting; clotting time ... See more keywords